Skip to main content
. 2023 Jun 21;2023(6):CD014788. doi: 10.1002/14651858.CD014788.pub2

Minaguchi 1986.

Study characteristics
Methods Trial design: Randomised, multi‐centre study
Participants Participants: 191 women were randomised and analysed.
Mean age: not stated
Inclusion criteria: 
  • Laparoscopically diagnosed endometriosis 

  • Over 18 years old patients who have received hormonal therapy 

  • Patients with persistent diagnosed endometriosis postoperatively 


Exclusion criteria: 
  • Patients receiving conservative surgery 


Setting: Japan 
Timing: not stated
Interventions Buserelin 300 mcg once daily intranasally for 6 months (n = 69) 
versus 
Buserelin 300 mcg twice daily intranasally for 6 months (n = 59) 
versus
Buserelin 300 mcg three times a day intranasally for 6 months (n = 63)
Outcomes
  • Relief of overall pain: Intermenstrual abdominal pain, lumbago, dyspareunia, pain on defecation, pelvic tenderness

  • Adverse effects

  • Flexibility of the uterus

  • Nodules in the posterior cul‐de‐sac

  • Endometrial cyst 

Notes Intention‐to‐treat analysis: not stated
Sample size calculation: not stated
Funding:  not stated
Note previous version: Authors contacted regarding methods and data; awaiting response
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk No details were provided of method used to generate the randomisation sequence.
Allocation concealment (selection bias) Unclear risk "Envelope". No further details were provided of method used to conceal treatment group allocation.
Blinding of participants and personnel (performance bias)
All outcomes Unclear risk No information about blinding; open‐label study
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk No information about blinding; open‐label study
Incomplete outcome data (attrition bias)
All outcomes Low risk All women who were randomised were analysed.
Selective reporting (reporting bias) Low risk The study protocol was not available but it was clear that the published reports included all expected outcomes, including those that were prespecified.
Other bias Low risk No other risk of bias detected